EUVIMEDEUVIMED entdecken
Crossref

MYC ‐Mediated Osseous Regeneration via BMSCs / PRP /β‐ TCP / PCL Bioprinted Constructs: Rapid Defect Rehabilitation and Preliminary Clinical Efficacy Evaluation

Dinghao Luo, Zhaoyang Ran, Junxiang Wu, Lei Wang, Wen Wu, Kai Xie, Liang Deng, Yongqiang Hao iD

IUBMB Life · 2025

DOI: 10.1002/iub.70036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUBMB Life, 2025. Verfasst von Dinghao Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Bone Regeneration, Mesenchymal Stem Cells, Platelet-Rich Plasma, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Key R&D Program of China, General Program of NSFC, Special Fund for Promoting High-quality Industrial Development of Shanghai Municipal Commission of Economy and Informatization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone defects present significant clinical challenges due to their morphological heterogeneity and structural complexity, necessitating regenerative strategies that integrate structural adaptability, biomechanical stability, and osteogenic potential. In this study, a bioengineered construct composed of bone marrow mesenchymal stem cells (BMSCs), platelet‐rich plasma (PRP), polycaprolactone (PCL), and β‐tricalcium phosphate (β‐TCP) was fabricated using 3D bioprinting. In vitro assays assessed osteoprogenitor cell proliferation (CCK‐8), migration (Transwell), differentiation (ALP staining), and endothelial tubulogenesis (Matrigel assay). In vivo bone regeneration was evaluated using a rabbit femoral condyle defect model, with histomorphometric analysis (Masson and COL‐1 staining). Mechanistic insights were explored via RNA sequencing and western blot analysis. Clinical validation included pre‐ and postoperative assessments of visual analog scale (VAS) scores and computed tomography (CT) imaging in patients with osseous defects. The bioprinted constructs significantly enhanced BMSCs proliferation ( p < 0.01), migration ( p < 0.0001), and ALP activity ( p < 0.0001), while promoting endothelial tubulogenesis ( p < 0.01). In vivo, the BMSCs/PRP/PCL/β‐TCP group exhibited greater Masson staining and collagen type I expression than controls at 2 weeks, 1 month, and 6 months postoperatively. Clinically, VAS scores significantly decreased (3.33 ± 1.63 pre‐op vs. 0.50 ± 0.84 post‐op, p = 0.005) with no severe complications. PRP concentration‐dependently upregulated MYC expression (mRNA: p < 0.0001; protein: p < 0.0001), while MYC knockdown abrogated PRP‐induced ALP and RUNX2 expression, confirming MYC's regulatory role in osteogenesis. In conclusion, BMSCs/PRP/PCL/β‐TCP bioprinted constructs enhance MYC‐mediated bone regeneration, demonstrating promising clinical potential for bone defect repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone RegenerationMesenchymal Stem CellsPlatelet-Rich PlasmaProto-Oncogene Proteins c-mycAnimalsCalcium PhosphatesPolyestersRabbitsHumansTissue ScaffoldsOsteogenesisBioprintingMaleCell ProliferationTissue EngineeringCell DifferentiationFemalePrinting, Three-DimensionalCells, Cultured

Stichwörter der Autor:innen

3D bioprintingMYCPRPbone regenerationclinical efficacy

Substanzen

beta-tricalcium phosphatepolycaprolactoneCalcium PhosphatesPolyestersProto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • Department of Orthopedics, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Key Laboratory of Orthopedic Prostheses, Shanghai, China.
  • 3D Printing Technology Clinical and Translational Research Center, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Engineering Research Center of Orthopedic Prostheses and Personalized Medical Equipment, Shanghai, China.

ORCID-Profile: Yongqiang Hao

Förderung

  • National Key R&D Program of China
  • General Program of NSFC
  • Special Fund for Promoting High-quality Industrial Development of Shanghai Municipal Commission of Economy and Informatization
  • Emerging Frontier Research Program of Shanghai Shenkang Hospital Development Center
  • "Clinical+" Program of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
  • National Natural Science Foundation of China
  • Shanghai Key Clinical Specialty Construction Project-Biomedical Materials
  • Huangpu District Biomedical Industry Policy Project Fund

Zitieren

APA

Luo, D., Ran, Z., Wu, J., Wang, L., Wu, W., Xie, K., Deng, L., & Hao, Y. (2025). MYC ‐Mediated Osseous Regeneration via BMSCs / PRP /β‐ TCP / PCL Bioprinted Constructs: Rapid Defect Rehabilitation and Preliminary Clinical Efficacy Evaluation. IUBMB Life. https://doi.org/10.1002/iub.70036

Vancouver

Luo D, Ran Z, Wu J, Wang L, Wu W, Xie K, et al. MYC ‐Mediated Osseous Regeneration via BMSCs / PRP /β‐ TCP / PCL Bioprinted Constructs: Rapid Defect Rehabilitation and Preliminary Clinical Efficacy Evaluation. IUBMB Life. 2025. doi:10.1002/iub.70036

BibTeX
@article{Luo2025,
  author = {Luo, Dinghao and Ran, Zhaoyang and Wu, Junxiang and Wang, Lei and Wu, Wen and Xie, Kai and Deng, Liang and Hao, Yongqiang},
  title = {MYC ‐Mediated Osseous Regeneration via BMSCs / PRP /β‐ TCP / PCL Bioprinted Constructs: Rapid Defect Rehabilitation and Preliminary Clinical Efficacy Evaluation},
  journal = {IUBMB Life},
  year = {2025},
  doi = {10.1002/iub.70036}
}
Kostenlos starten →